Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Roquefort Therapeutics PLC - UK-based biotech company - Forms scientific advisory board to provide scientific guidance on strategy, as the company moves towards key pre-clinical milestones and clinical trials. Says SAB will initially comprise of Jo Martin, Trevor Jones and Armand Keating. Aims to use their drug development expertise to complete pre-clinical development to reach valuation milestones for licensing transactions or sale of a clinical programme.
Current stock price: 7.30 pence, down 12%
12-month change: down 20%
Copyright 2023 Alliance News Ltd. All Rights Reserved